I already emailed NP about the NIH long hauler 1.5 Billion dollars for trials and they also are doing a CD16 type trial NIAID5 for therapeutics. Support the development and distribution of reagents and viral isolates to researchers. NIAID will continue to support both intramural and extramural researchers by developing reagents and assays for virus characterization and immunological analyses.



We should go after this money, the FDA can save face if we can let go of the defensive posture.